Improving deep imaging techniques for living tissues
Toward fast and deep imaging of living tissue with cellular resolution
This study is exploring a new way to take super-clear pictures of living tissues using a special imaging technology, which could help doctors better understand and treat conditions related to the brain, immune system, and cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project ID | NIH-11092226 on NIH RePORTER |
What this research studies
This research focuses on advancing a new imaging technology called three-photon fluorescence microscopy (3PM) to achieve high-resolution imaging of living tissues. By overcoming challenges related to signal strength and laser optimization, the project aims to enhance the ability to visualize dynamic cellular processes in various organs beyond the brain. Patients may benefit from improved diagnostic and treatment options in fields like neuroscience, immunology, and cancer biology as this technology matures.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that affect deep tissues, such as neurological disorders, cancers, or immune system diseases.
Not a fit: Patients with superficial tissue conditions or those not requiring deep tissue imaging may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in how we visualize and understand cellular processes in living tissues, potentially improving patient outcomes in various medical fields.
How similar studies have performed: While three-photon microscopy is a relatively new approach, initial applications have shown promise in imaging brain structures, indicating potential for success in other biological systems.
Where this research is happening
Ithaca, United States
- Cornell University — Ithaca, United States (Active)
Researchers
- Principal investigator: Xu, Chris — Cornell University
- Study coordinator: Xu, Chris
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.